Richard Pzena's HALO Position Overview
Richard Pzena (via Pzena Investment Management LLC) currently holds 4,107 shares of Halozyme Therapeutics, Inc. (HALO) worth $301,207, representing 0.00% of the portfolio. First purchased in 2022-Q1, this short-term holding has been held for 6 quarters.
Based on 13F filings, Richard Pzena has maintained this position in HALO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2022, adding 14,507 shares. Largest reduction occurred in Q2 2022, reducing 15,738 shares.
Analysis based on 13F filings available since 2013 Q2
Richard Pzena's Halozyme Therapeutics (HALO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Halozyme Therapeutics (HALO) Trades by Richard Pzena
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2022 | +15,738 | New Buy | 15,738 | $39.90 |
| Q2 2022 | -15,738 | Sold Out | 0 | $0.00 |
| Q4 2022 | +14,507 | New Buy | 14,507 | $56.90 |
| Q1 2023 | -5,291 | Reduce 36.47% | 9,216 | $38.19 |
| Q2 2023 | -9,216 | Sold Out | 0 | $0.00 |
| Q3 2025 | +4,107 | New Buy | 4,107 | $73.34 |
Richard Pzena's Halozyme Therapeutics Investment FAQs
Richard Pzena first purchased Halozyme Therapeutics, Inc. (HALO) in Q1 2022, acquiring 15,738 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Richard Pzena has held Halozyme Therapeutics, Inc. (HALO) for 6 quarters since Q1 2022.
Richard Pzena's largest addition to Halozyme Therapeutics, Inc. (HALO) was in Q1 2022, adding 15,738 shares worth $628,000.
According to the latest 13F filing for Q3 2025, Richard Pzena's firm, Pzena Investment Management LLC, owns 4,107 shares of Halozyme Therapeutics, Inc. (HALO), valued at approximately $301,207.
As of the Q3 2025 filing, Halozyme Therapeutics, Inc. (HALO) represents approximately 0.00% of Richard Pzena's publicly disclosed stock portfolio, making it one of their key holdings.
Richard Pzena's peak holding in Halozyme Therapeutics, Inc. (HALO) was 15,738 shares, as reported at the end of Q1 2022.